What does Tvardi Therapeutics, Inc. do?
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The…
What is Tvardi Therapeutics, Inc.'s P/E and P/B ratio?
Tvardi Therapeutics, Inc. has a P/E ratio of -0.3 and a P/B ratio of 1.55.
What is Tvardi Therapeutics, Inc.'s debt-to-equity ratio?
Tvardi Therapeutics, Inc. has a debt-to-equity ratio of 0.02.
How much does Tvardi Therapeutics, Inc. owe compared with what it owns?
Tvardi Therapeutics, Inc. owes $0.52 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Tvardi Therapeutics, Inc.'s Positivity rank?
Tvardi Therapeutics, Inc. is ranked #1,026 of 6,774 companies globally and #193 of 4,000 in United States on PositoAI, with a Positivity Score of 23,329.
Does Tvardi Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Tvardi Therapeutics, Inc..
Where can I read the latest news about Tvardi Therapeutics, Inc.?
Recent headlines about Tvardi Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Tvardi Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Tvardi Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.